Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia

By Anargyrou Konstantinos   Vaiopoulos George   Terpos Evangelos   Tsironi Maria   Konstantopoulos Konstantinos   Samarkos Michael   Meletis John  

Haematologia, Vol. 32, Iss. 2, 2002-06 ,pp. : 169-173

VSP

Access to resources Recommend Favorite

High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children

By Tempescul Adrian  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 503-504

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia

By Pakakasama Samart   Kanchanakamhaeng Kittima   Kajanachumpol Saowanee   Udomsubpayakul Umaporn   Sirachainan Nongnuch   Thithapandha Amnuay   Hongeng Suradej  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 609-611

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell rescue for acute myeloid leukemia remains a safe, effective, and valid option

By Hwang Y.K.W.   Goh Y.T.   Linn Y.C.   Tan C.H.   Tan H.C.P.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2464-2466

Elsevier

Access to resources Recommend Favorite

Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia

By Shadman Mazyar   Estey Elihu H  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 131-133

Informa Healthcare

Access to resources Recommend Favorite